Follow the 亚辉龙 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 亚辉龙 has published 15 public disclosures. Market capitalisation: €5.9bn. The latest transaction was disclosed on 8 September 2026 (Purchase). Among the most active insiders: 胡鹍辉. Every trade is openly available.
15
Insider Decl.
n/a
Thresholds
€754,636
5 ops.
Buy Volume
€5m
10 ops.
Sell Volume
22Σ signal
Buys €754,636€5m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,523 of 29,063 companies
43.3
score / 100
Value
36
Quality
50
FCF yld1.1%
Earn yld0.4%
EV/EBITDA16.8x
ROE4.3%
Gross mgn65%
Net mgn1.3%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
亚辉龙 es una empresa del sector de la salud y farmacéutico, cotizada en la Bolsa de Shanghái. Se centra en el desarrollo y la producción de productos farmacéuticos innovadores.